FDA Approved: VABYSMO — Original Application (Genentech, Inc.)

View source ↗

Summary

FDA approves VABYSMO (faricimab) for the treatment of neovascular age-related macular degeneration and diabetic macular edema under the original application sub…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Neovascular Age-related Macular Degeneration

Drugs mentioned

• VABYSMO (faricimab)

Snippet

ORIG AP for VABYSMO (FARICIMAB)